Difference between revisions of "Quan XX, et al. Mol. Cancer Ther. (2018) cited as Ref 409 in DOI: 10.1038/s41392-020-0110-5 (Q9672)"
Jump to navigation
Jump to search
(Created claim: title (P93): Targeting Notch1 and IKKalpha enhanced NF-kappaB activation in CD133(+) skin cancer stem cells, #quickstatements; #temporary_batch_1590010982689) |
(Created claim: Page(s) (P105): 2034-2048, #quickstatements; #temporary_batch_1590074839150) |
||
| Property / Page(s) | |||
| + | 2034-2048 | ||
| Property / Page(s): 2034-2048 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:40, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Quan XX, et al. Mol. Cancer Ther. (2018) cited as Ref 409 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Quan XX
0 references
2018
0 references
Mol. Cancer Ther.
0 references
17
0 references
Targeting Notch1 and IKKalpha enhanced NF-kappaB activation in CD133(+) skin cancer stem cells (English)
0 references
2034-2048
0 references
